The Alphavirus genus in the Togaviridae family contains a number of human and animal pathogens. The importance of alphaviruses has been strongly underappreciated; however, epidemics of chikungunya virus (CHIKV), causing millions of cases of severe and often persistent arthritis in the Indian subcontinent, have raised their profile in recent years. In spite of a continuous public health threat, to date no licensed vaccines have been developed for alphavirus infections. In this study, we have applied an accumulated knowledge about the mechanism of alphavirus replication and protein function in virus-host interactions to introduce a new approach in designing attenuated alphaviruses. These variants were constructed from genes derived from different, geographically isolated viruses. The resulting viable variants encoded CHIKV envelope and, in contrast to naturally circulating viruses, lacked the important contributors to viral pathogenesis: genes encoding proteins functioning in inhibition of cellular transcription and downregulation of the cellular antiviral response. To make these viruses incapable of transmission by mosquito vectors and to differentially regulate expression of viral structural proteins, their replication was made dependent on the internal ribosome entry sites, derived from other positive-polarity RNA (RNA ؉ ) viruses. The rational design of the genomes was complemented by selection procedures, which adapted viruses to replication in tissue culture and produced variants which (i) demonstrated different levels of replication and production of the individual structural proteins, (ii) efficiently induced the antiviral response in infected cells, (iii) were incapable of replication in cells of mosquito origin, and (iv) efficiently replicated in Vero cells. This modular approach to genome design is applicable for the construction of other alphaviruses with a programmed, irreversibly attenuated phenotype.
The Alphavirus genus in the Togaviridae family contains almost 30 currently known members, which are distributed on all continents (48) . Such a wide distribution implies evolution of the viruses in different, geographically isolated areas and their adaptation to different host and vector species. In mosquito vectors, alphaviruses cause a persistent, life-long infection that does not significantly interfere with the vectors' biological functions (59, 60) . These viruses accumulate to high concentrations in mosquito salivary glands and are transmitted to vertebrate hosts during the blood meal. In vertebrates, alphaviruses develop an acute infection, characterized by a high-titer viremia, required for virus transmission to new mosquitoes during blood ingestion and continuation of the infection cycle. The high rates of alphavirus replication and viremia development are critically determined by efficient function of viral genome replication machinery and rapid accumulation of virus-specific structural proteins in the infected cells. However, another important contributor to the infectious process is the ability of replicating virus to interfere with the development of the virus-induced cell response and ultimately with the innate immune response, which is aimed at inhibiting virus replication. Recent studies demonstrated that geographically isolated alphaviruses have developed different means to obstruct and slow down development of the antiviral response (2, 3, 6, 14, 22, 25, 26, 61) .
The alphavirus genome is a single-strand RNA of positive polarity that mimics the structure of the eukaryotic messenger RNAs (47, 50) in that it has a cap at the 5Ј terminus and a poly(A) tail at the 3Ј terminus. The genome encodes only 4 nonstructural (ns) proteins, nsP1 to -4, which are translated directly from the genomic RNA and interact with host factors to form replicative enzyme complexes (8, 34, 35) . These complexes synthesize the negative-strand RNA intermediates, new viral genomes, and the subgenomic RNA. The 26S subgenomic RNA serves as a template for translation of the structural proteins: capsid and glycoproteins E2 and E1, which ultimately form infectious viral particles (43) .
In contrast to some other viruses, alphaviruses do not express proteins, which are extraneous for RNA replication and virion formation. Instead, they utilize the same structural and nonstructural proteins to function not only in virus replication but also in interference with the cellular antiviral response (24) (25) (26) . Both the New World and Old World alphaviruses demonstrate an ability to inhibit cellular transcription (2) (3) (4) (24) (25) (26) and use it as an efficient means of disruption of the cellular antiviral reaction. The Old World alphavirus nonstructural protein nsP2 was found to accumulate in the nuclei of the infected cells and is critically involved in transcription inhibition, though the molecular mechanism remains under investigation (5, 22, 44, 45) . The New World alphaviruses, in contrast, utilize their capsid protein, and not nsP2, to achieve transcriptional shutoff (2, 26) . The capsid protein binds both importin ␣/␤ and exportin CRM1 receptors and blocks nuclear pore complex function. The resulting inhibition of nuclear cytoplasmic trafficking strongly correlates with the development of capsid-dependent transcriptional shutoff (3, 4) . Mutated variants of New World alphaviruses containing point mutations in capsid (6) and Old World alphaviruses with mutations in nsP2 (22, 28) demonstrate a dramatically less cytopathic phenotype, induce a high level of type I interferon, and spread inefficiently in cell lines capable of type I interferon expression and signaling.
This new knowledge of virus-host cell interactions creates an interesting opportunity for the rational design of attenuated alphaviruses, which are incapable of inhibiting the cellular antiviral response. Such viruses may be able to initiate replication in vivo. However, rapid development of the antiviral response, which is downregulated by wild-type (wt) viruses, would prevent subsequent rounds of infection and thus development of a high-titer viremia. This approach appears to be readily applicable to the New World alphaviruses, such as Venezuelan (VEEV), eastern (EEEV), and western (WEEV) equine encephalitis viruses, in which only a small peptide in the capsid protein is responsible for transcription inhibition. It can be modified by multiple redundant mutations without affecting capsid function in virus assembly (1, 3, 6) . However, similar modifications of the Old World alphavirus nsP2 are likely to be more difficult to perform. The latter protein has numerous activities in ns polyprotein processing and RNA replication, and modifications in nsP2 have a deleterious effect on virus replication (17, 19, 41) . Thus, it cannot tolerate multiple point mutations or more significant modifications, which usually have strong adverse affects on different aspects of virus biology. Moreover, virus variants containing point mutations in nsP2 readily revert to the wt phenotype during replication in cells competent in interferon (IFN) signaling (I. Frolov, unpublished data). This instability greatly complicates the application of nsP2 mutants for vaccine development. Therefore, the design of stable, attenuated Old World alphaviruses, such as chikungunya virus (CHIKV), requires new approaches.
One of the possibilities is designing chimeric viruses which combine the New World alphavirus nsP2 gene and the Old World alphavirus-specific capsid gene in their genomes (26, 57) . Such variants express no protein capable of functioning in transcription inhibition, and their further evolution to a pathogenic phenotype appears to be a very unlikely event. In our recent studies, we have constructed chimeric viruses (VEE/ CHIKV and EEE/CHIKV) which combine the nsP genes derived from VEEV TC-83 and EEEV BeAr436087, respectively, with the structural genes from CHIKV La Reunion (LR) strain (57) . These viruses demonstrated a highly attenuated phenotype in mice but induced neutralizing, CHIKV-specific antibodies (57) . In this study, we have demonstrated the unique features of the recombinant, chimeric viruses and tested a number of strategies to make them incapable of replication in insect cells.
MATERIALS AND METHODS
Cell cultures. BHK-21 cells were kindly provided by Sondra Schlesinger (Washington University, St. Louis, MO). NIH 3T3 cells were obtained from the American Type Culture Collection (ATCC) (Manassas, Va). Vero cells were kindly provided by Charles Rice (Rockefeller University, New York, NY). These cell lines were maintained at 37°C in alpha minimum essential medium (␣MEM) supplemented with 10% fetal bovine serum (FBS) and vitamins. Mosquito C7/10 cells were obtained from Henry Huang (Washington University, St. Louis, MO) and propagated in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% heat-inactivated FBS and 10% tryptose phosphate broth (TPB).
Plasmid constructs. All of the plasmids containing recombinant alphavirus genomes were designed using PCR-mediated mutagenesis, PCR-mediated ligation, and standard cloning procedures. All of the constructs and mutations introduced into the wt sequences are presented in the corresponding figures. Before cloning into infectious cDNA, all of the fragments generated by PCR were sequenced to avoid any PCR-mediated spontaneous mutations. Sequences of all of the recombinant plasmids can be provided upon request.
RNA transcriptions. Plasmids were purified by centrifugation in CsCl gradients. Before being subjected to a transcription reaction, plasmids were linearized using the MluI or NotI restriction sites located downstream of the poly(A) sequence. RNAs were synthesized by SP6 or T7 RNA polymerase in the presence of a cap analog using previously described conditions (42) . The yield and integrity of transcripts were analyzed by gel electrophoresis under nondenaturing conditions. The RNA concentration was measured on a Fotodyne imager, and transcription reaction mixtures containing 1 g of full-length RNA were used for electroporation (37) without additional purification.
Infectious center assay, analysis of virus replication and generation of viral stocks. One microgram of in vitro-synthesized, full-length RNA transcripts of viral genomes was used per electroporation of BHK-21 cells. Different numbers of electroporated cells were seeded in six-well Costar plates containing subconfluent naive cells. After 1 h of incubation at 37°C in a 5% CO 2 incubator, cells were overlaid with 2 ml of MEM-containing 0.5% Ultra-Pure agarose (Invitrogen) supplemented with 3% FBS. Chimeric viruses demonstrated different levels of cytopathogenicity, but all of them were capable of forming plaques under agarose cover in the presence of FBS at the indicated low concentration. Plaques were stained with crystal violet after 2 or 3 days of incubation at 37°C.
Two milliliters (one-fifth) of the electroporated cells were seeded in 35-mm dishes, media were replaced at various times, and titers were determined by a plaque assay on BHK-21 or Vero cells as previously described (33) . The rest of the cells were seeded into 100-mm dishes and media were harvested at 24 h postelectroporation and, after determination of the titer by plaque assay on Vero cells (33) , used as virus stocks.
Adaptation of the viruses was performed by serial passage on Vero cells. At every passage, a 10-fold smaller volume of the media was used for inoculation. After 5 to 7 blind passages, virus titers were determined, and the genomes of the plaque-purified variants were sequenced to identify the adaptive mutations. The mutations were introduced into infectious cDNAs of the original constructs, and viral stocks were generated as described above.
Viral replication analysis. Cells were seeded at a concentration of 5 ϫ 10 5 cells/35-mm dish. After 4 h of incubation at 37°C, monolayers were infected at appropriate multiplicities of infection (MOIs) for 1 h, washed with phosphatebuffered saline (PBS), and overlaid with 1 ml of complete medium. At the times indicated in the figures, media were replaced by fresh media, and virus titers were determined by a plaque assay on Vero cells (33) . In some of the experiments, the same media were used for measuring the concentration of alpha/beta IFN (IFN-␣/␤). After this incubation, they were scraped into the media, pelleted at 1,500 rpm, and dissolved in 100 l of standard protein loading buffer. Equal amounts of protein were loaded in each lane of sodium dodecyl sulfate-10% polyacrylamide gels. After electrophoresis, the gels were dried, autoradiographed, and analyzed on a Storm 860 PhosphorImager (Molecular Dynamics). The amounts of radioactivity detected in the protein band corresponding to capsid and other viral structural proteins were determined.
Analysis of RNA synthesis. To analyze the synthesis of the virus-specific RNAs, the infected cells were metabolically labeled with [ 3 H]uridine (20 Ci/ml) in the presence of actinomycin D (ActD) (1 g/ml) for 4 h, beginning at 4 h postinfection (see the figure legends for details). Total cellular RNA was isolated by TRizol according to the protocol recommended by the manufacturer (Invitrogen) and then denatured with glyoxal in dimethyl sulfoxide and analyzed by agarose gel electrophoresis, using previously described conditions (13) . After autofluorography, RNA bands were excised from the gels and radioactivity was measured by liquid scintillation counting.
IFN-␣/␤ assay.
In the early experiments, concentrations of IFN-␣/␤ in the media were measured by a previously described biological assay (22) . In most of the later experiments, concentrations of murine IFN-␤ in the media were determined by the VeriKine mouse interferon beta enzyme-linked immunosorbent assay (ELISA) kit (PBL Interferon Source).
GeneChip expression analysis. NIH 3T3 cells were seeded at a concentration of 2.5 ϫ 10 6 cells per 100-mm dish. After 4 h of incubation at 37°C, cells were infected by various virus variants at an MOI of 20 PFU/cell in PBS supplemented with 1% FBS. After 1 h of infection at 37°C, PBS was replaced by complete medium, and incubation continued for 16 h at 37°C. RNAs from the infected and mock-infected cells were isolated by using TRIzol reagent as recommended by the manufacturer (Invitrogen) and additionally purified by the RNeasy minikit (Qiagen). After the RNA quality was tested and the concentration was assessed, the GeneChip analysis was performed in the UAB core facility. Expression data analysis was performed using the GeneSpring software program, version GX 11.5 (Agilent). Raw intensity values were normalized using the robust multichip average (RMA) algorithm. Normalized fluorescence intensity values from infected and uninfected NIH 3T3 cells were compared to reveal the transcripts whose expression was altered more than threefold. Selected genes were divided in groups according to Gene Ontology (GO) classification.
Animal studies. CD1 outbred mice were obtained from Charles River (Wilmington, MA). They were subcutaneously (s.c.) infected with 10 5 PFU of the indicated viruses. Blood samples were collected from the retroorbital sinus at days 28 and 120 after infection, and titers of CHIKV-specific antibodies (Abs) were measured in a plaque reduction neutralization test (PRNT 80 ).
All animal studies were approved by the UTMB Institutional Animal Care and Use Committee.
RESULTS
In a previous study, we generated novel alphavirus genomic constructs containing nonstructural and structural proteins derived from different alphaviruses. These genetic manipulations resulted in recombinant chimeras (VEE/CHIKV, EEE/ CHIKV, and SIN/CHIKV) (57) . Their structural genes were derived from the CHIKV LR strain, while the ns polyproteincoding genes and RNA promoters were derived from either the VEEV vaccine strain TC-83, the EEEV South American strain BeAr436087, or the Sindbis virus (SINV) AR339 strain. All of these viruses demonstrated an attenuated phenotype in mice and were capable of inducing a protective immune response against the subsequent CHIKV infection (57) . In designing the VEE/CHIKV and EEE/CHIKV chimeras, we sought to produce a virus variant incapable of interfering with the antiviral response to the same level as the nonchimeric parental viruses. Therefore, we combined in the recombinant genomes the New World alphavirus (VEEV and EEEV) nsP2 and Old World alphavirus (CHIKV) capsid genes, whose products have no functions in cellular transcription inhibition (24) (25) (26) . An attenuated phenotype in the SIN/CHIKV chimera was expected because of inefficient replication in vivo due to the SINV-specific backbone and possibly less-efficient viral genome packaging by the heterologous CHIKV-specific structural proteins.
While VEE/CHIKV and EEE/CHIKV were viable and produced infectious viruses directly after electroporation of the in vitro-synthesized RNA, the SIN/CHIKV strain required an additional modification, deletion of nucleotide 9 in the 5Ј untranslated region (5ЈUTR) of subgenomic RNA, which resulted in improved virus replication and release to detectable levels (57) . The construct containing the nucleotide 9 deletion was used for all of the SIN/CHIKV-related experiments in this study.
The parental VEEV TC-83, EEEV BeAr436087, and SINV AR339 strains are cytopathic in most of the traditionally used cell lines. However, VEE/CHIKV and EEE/CHIKV demonstrate a poorly cytopathic phenotype due to their inability to express proteins with nuclear functions, i.e., Old World alphavirus nonstructural protein (nsP2) or New World alphavirus capsid. SIN/CHIKV retained a cytopathic phenotype, which appeared to be strongly determined by SINV nsP2. To follow the spread of infection and virus replication, in this study, we designed and applied recombinant viruses and control VEEV TC-83 and SINV variants which expressed GFP from a second subgenomic promoter (Fig. 1A) . EEEV BeAr436087 was not used in any experiments for biosafety reasons.
All of the GFP-expressing constructs (Fig. 1A) were viable, and in the infectious center assay, the in vitro-synthesized RNAs demonstrated very similar infectivities, indicating that no adaptive mutations were required for replication and infectious virus release (data not shown). VEEV/GFP, SINV/GFP, and SIN/CHIKV/GFP caused a profound cytopathic effect (Fig. 1D) . Their clearance correlated with the induction of IFN-␣/␤, which was readily detected in the incubation medium (Fig. 1E) . Moreover, at a low MOI, these viruses were incapable of developing a spreading infection in the NIH 3T3 or other cells having the intact type I IFN signaling (data not shown). Thus, VEE/ CHIKV/GFP and EEE/CHIKV/GFP viruses demonstrated the predicted characteristics, i.e., they were noncytopathic and incapable of inhibiting the type I IFN response.
Adaptation of chimeric viruses to Vero cells. Further modifications of chimeric viruses and characterization of their replication required the infection of the monolayers with homogeneous viral stocks. However, alphavirus natural isolates usually demonstrate a tendency to further evolution that results in a higher positive charge of the E2 glycoprotein, increasing infectivity of the virions in the in vitro experiments. This appears to be an unavoidable process, and therefore we introduced into CHIKV LR-specific E2 of all of the chimeras an adaptive mutation, W64 3 R, which we have previously detected in EEE/CHIKV after serial passaging in Vero cells (57) . Surprisingly, this adaptive mutation demonstrated function in a virus-dependent mode. It had only a minor positive impact on SIN/CHIKV titers and replication rates in Vero cells but strongly increased the titers of EEE/CHIKV (Fig. 2) . The same mutation also resulted in detectably increased infectious titers of VEE/CHIKV. However, after 5 additional passages on Vero cells, we selected a variant which produced noticeably larger plaques and acquired an additional E2-specific mutation, N72 3 Y. Cloning of this mutation into VEE/CHIKV, already bearing the W64 3 R mutation, caused a further increase in infectious titers of the chimeric virus. The designed chimeras with an adaptive mutation(s) in E2 were applied for further Chimeric viruses induce a strong cellular response. To compare the abilities of the chimeras to interfere with induction of cellular genes, we infected NIH 3T3 cells with the chimeric viruses encoding the CHIKV E2 glycoprotein with and without adaptive mutations and compared mRNA profiles at 16 h postinfection in microarray-based experiments (Fig. 3) . The SIN/CHIKV chimera, which encodes the cellular transcription-inhibiting SINV nsP2 (25, 26) , induced almost no cellular genes, whereas more than 1,300 mRNAs were present in Ͼ3-fold lower concentrations. In contrast, infections with VEE/ CHIKV and EEE/CHIKV caused a greater than 3-fold upregulation of 386 and 238 transcripts, respectively. A large fraction of the induced genes encode IFN and IFN-regulated proteins (115 and 85 in VEE/CHIKV and EEE/CHIKV samples, respectively). The second group of interest included genes involved in cell signaling (49 and 23 for VEE/CHIKV and EEE/CHIKV, respectively). Both viruses also induced a wide variety of genes whose products are involved in protein transport, ubiquitin-mediated protein degradation, and antigen presentation. None of these genes were upregulated in SIN/CHIKV-infected NIH 3T3 cells. Among the genes downregulated in VEE/CHIKV-and EEE/CHIKV-infected cells, ϳ30% were represented by those governing the cell cycle. The set of cellular mRNA templates, which were present at lower concentration in SIN/CHIKV-infected NIH 3T3 cells, corresponded to the proteins involved in various aspects of cellular metabolism. These data strongly correlate with the SIN/ CHIKV cytopathic phenotype in this cell line. We found no differences between the spectra of induced genes and concentrations of the corresponding mRNAs between the samples isolated from cells infected with the chimeras expressing wt E2 and those variants containing an adaptive mutation(s) in the E2 glycoprotein (data not shown).
These data strongly correlated with the ability of the VEE/ CHIKV and EEE/CHIKV chimeras to induce the type I IFN response and demonstrated the following. (i) These chimeric alphaviruses, encoding the nsP2 and capsid proteins lacking a direct function in regulation of cellular transcription, are inca- pable of efficient interference with the development of the virus-induced cell response. (ii) Adaptive mutations in CHIKV E2 have no effect on the ability of chimeric viruses to induce transcription of cellular genes. (iii) The VEE/CHIKV chimera has the strongest stimulatory effect on activation of cellular antiviral genes. Therefore, this chimeric virus with the abovedescribed adaptive mutations in the E2 glycoprotein was used for further modifications.
Three different strategies can be applied for making alphavirus replication dependent on IRES. The construction of chimeric arboviruses raises the concern that they may be disseminated among mosquito vector populations and thus become involved in the natural transmission cycle. In mosquito species, alphaviruses cause a life-long persistent infection, which might create an opportunity for their further evolution and adaptation for natural circulation. To avoid this problem, in our previous study, we tested the possibility of making alphavirus replication dependent on cis-acting RNA elements that do not function in insect cells (55) . Internal ribosome entry sites (IRESes) derived from the nonarthropod viruses appear to satisfy this requirement, and placement of alphavirus structural genes under the control of the encephalomyocarditis virus (EMCV) IRES made VEEV TC-83 incapable of replication in mosquito cells (55) . In the present study, we initially designed a VEE/IRES/CHIKV variant, in which the subgenomic pro- (Fig. 4A) . The natural 5ЈUTR of the subgenomic RNA was replaced by the EMCV IRES to drive translation of the CHIKV structural proteins. One of the designed constructs (VEE/IRES/CHIKV) encoded unmodified VEEV nsPs, and the second (VEE/IRES/CHIKV1) contained a mutation, Y370 3 C, in nsP2, which we had detected previously in tissue culture-adapted VEEV/IRES (55). The designed IRES-dependent, chimeric viruses were viable but replicated in BHK-21 cells at lower rates than the subgenomic promoter-containing VEEV/CHIKV (Fig. 4B) . The nsP2-specific mutation in VEE/ IRES/CHIKV1 had a positive impact on replication, but levels remained below that of VEE/CHIKV, which contained no IRES. The lower levels of virus replication correlated with inefficient synthesis of viral structural proteins: the IRES-containing chimeras produced CHIKV structural proteins at approximately 10% of the level found in VEE/CHIKV-infected cells (Fig. 4C) . Thus, the IRES-containing variants demonstrated slower growth, which could be beneficial for virus attenuation in vivo. However, the low levels of CHIKV structural protein production could result in overattenuation and poor immunogenicity (55) . Therefore, we investigated a number of alternative approaches to designing IRES-containing viruses with high expression of viral structural proteins, particularly the envelope proteins E1 and E2. To increase CHIKV glycoprotein expression, we designed a recombinant viral genome encoding the VEEV TC-83 replicative machinery (nsP1 to -4) and the VEEV-specific promoter of the subgenomic RNA (see VEE/CHIKV/IRESe/C in Fig.  5A ). In this construct, the capsid gene was cloned downstream of the glycoprotein-coding sequence and placed under the translational control of the EMCV IRES. Considering the possibility that, as in the case of SINV (20, 21) , the VEEV 5ЈUTR of the subgenomic RNA and the beginning of the capsid-coding sequence may promote efficient translation, the CHIKV glycoprotein-coding sequences were fused with the 45 amino-terminal codons of VEEV capsid through the foot-andmouth disease virus (FMDV) 2A protease, which mediated processing between the capsid fragment and the E3 glycoprotein (Fig. 5A) . The first 45 amino acids of the VEEV capsid protein do not encode a peptide critical for the inhibition of nucleocytoplasmic trafficking or CPE development during VEEV replication (3).
This construct was viable, and in the infectious center assay, the in vitro-synthesized RNA demonstrated the same efficiency of plaque formation as that of VEEV TC-83 (1 ϫ 10 6 to 2 ϫ 10 6 PFU/g of RNA). At 24 h postelectroporation, the titer of . Equal amounts of cell lysates were analyzed by SDS-PAGE followed by autoradiography, and the same gel was also analyzed on a PhosphorImager to assess synthesis of capsid protein.
the recombinant virus exceeded 10 8 PFU/ml (Fig. 5A) . However, seven passages of the harvested virus in Vero cells with decreasing MOI led to the selection of better-replicating variants. Sequencing of the ns polyprotein-coding sequence in the randomly selected, plaque-purified variants demonstrated accumulation of additional mutations in the nsP2 gene (K139 3 N and K628 3 E). Cloning of these mutations into the original construct (see VEE/CHIKV/IRESe/C in Fig. 5A ) significantly increased virus titers and replication rates ( Fig. 5A and B) .
Titers and replication rates of the subgenomic promotercontaining chimeras, VEE/CHIKV and VEE/CHIKV/IRESe/ C1, were very high. The reason for such robust replication was additionally investigated by metabolic labeling of the virusspecific RNAs in the infected cells and analysis of subgenomic and genomic RNA synthesis. The results presented in Fig. 5C demonstrate that the distinguishing feature of the chimeric viruses is the high molar ratio of subgenomic to genomic (SG/G) RNA synthesis. In agreement with the previously published data (27, 32) , wild-type VEEV TC-83 and SINV Toto1101 and also nonchimeric VEEV/IRESe/C synthesized 2-to 5-fold more molecules of subgenomic RNA than of genomic RNA. In contrast, the chimeric viruses encoding CHIKV structural proteins demonstrated an SG/G ratio above 15. The adaptive mutations in nsP2 of VEE/CHIKV/IRESe/C1 additionally increased production of SG RNA. This variant produced 37-fold more subgenomic than genomic RNA. The reason for such an efficient function of the subgenomic promoter in chimeric viruses is not clear, but this is probably an additional demonstration that our knowledge about the promoter structure and the role(s) of structural proteins in regulation of alphavirus RNA synthesis is very far from complete.
The design of viruses containing additional cis-acting elements controlling replication and expression of individual structural proteins opens an interesting opportunity for differential regulation of their expression. Therefore, we made an attempt to decrease capsid protein synthesis without affecting that of the glycoproteins. To achieve this, we initially utilized IRESes derived from different, inefficiently replicating RNA viruses for glycoprotein production. Hepatitis C virus (HCV) and bovine viral diarrhea virus (BVDV) IRESes were cloned into VEE/CHIKV/IRESe/C1 to replace the EMCV IRES (Fig.  6A) . The resulting VEE/CHIKV/IRESh/C1 and VEE/CHIKV/ IRESb/C1 constructs were viable, producing levels of RNA replication similar to those of VEE/CHIKV/IRESe/C1 RNA in the infectious center assay (data not shown) and also similar rates of infectious virion production (Fig. 6B) . Further analysis of virus-specific protein synthesis strongly suggested that in the context of the VEEV TC-83 backbone, EMCV, BVDV, and HCV IRESes functioned equally efficiently in terms of CHIKV capsid protein expression (Fig. 6C) . In infected Vero cells, the subgenomic RNAs of chimeric viruses utilized most of the cellular translational machinery, and total radioactivity in the structural proteins bands, capsid pE2 and E1, was at ϳ50% of the level of the entire pool of the proteins synthesized in the mock-infected cells (data not shown). Thus, these data indicated that possible differences in the efficiencies of different IRESes in driving capsid expression were compensated for by highly efficient synthesis of the subgenomic RNA and its accumulation to a level which saturated the translational machinery.
Based on these data, we tested another approach aimed at decreasing capsid protein but not glycoprotein E2 and E1 production. The EMCV IRES/capsid gene cassette was cloned into the chimeric virus genome upstream of the subgenomic RNA. The expression of the glycoproteins E2 and E1 was controlled by the subgenomic promoter to achieve more efficient expression (see the VEE/IRES-C/CHIKV construct in Fig. 7A ). As we expected, this construct was viable, but its replication depended on the presence and further accumulation of adaptive mutations in nsP2. The titers of the originally designed VEE/IRES-C/CHIKV construct encoding wt VEEV nsP2 were below 10 7 PFU/ml. Insertion of the K139 3 N and K628 3 E mutations selected in the context of VEE/CHIKV/ IRESe/C (Fig. 5) increased the titers more than 10-fold (Fig.  7A) . Further passaging of the latter virus in Vero cells led to selection of variants demonstrating even higher replication efficiency. The mutations responsible for this increase in virus replication were identified in nsP2 (L461 3 S and D548 3 G), and their subsequent cloning into the VEE/IRES-C/CHIKV construct resulted in both higher virus titers (Fig. 7A) and replication rates in Vero cells (data not shown and Fig. 8D ). The final VEE/IRES-C/CHIKV2 variant was capable of expressing glycoproteins with the same efficiency as (and even with higher efficiency than) the IRES-independent VEE/ CHIKV (Fig. 7B and C) . However, synthesis of capsid protein remained at the level comparable to that of the VEE/IRES/ CHIKV1 construct ( Fig. 7B and C) , which lacked the subgenomic promoter.
Comparative analysis of replication of the IRES-containing viruses. The above-described experiments produced three chimeric, IRES-containing variants encoding VEEV TC-83-derived replicative enzymes and 3Ј and 5Ј cis-acting promoter elements (Fig. 8A) . All of these were capable of expressing the entire set of CHIKV-specific structural proteins and thus were expected to be inefficient in suppression of the antiviral response in vertebrate cells. To confirm this, NIH 3T3 cells were infected with IRES-containing viruses and the controls, IRESindependent VEEV/CHIKV, VEEV TC-83, and SINV Toto1101. The latter two wt, nonchimeric alphaviruses induced either a barely detectable level of IFN-␤ (VEEV TC-83) or no detectable level of IFN-␤ at all (SINV Toto1101) (Fig. 8B) . However, replication of the chimeric viruses caused a high 35 S]methionine for 30 min at 37°C. Equal amounts of cell lysates were analyzed by SDS-PAGE followed by autoradiography, and the same gel was also analyzed on a PhosphorImager to assess synthesis of capsid protein.
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level of IFN-␤ production (note that 10 ng of IFN-␤ per ml corresponds to 1,000 IU/ml measured using a biological assay). These data strongly correlated with the results of microarray analysis of gene expression in infected mouse cells (Fig. 8C) . Replication of IRES-containing chimeras and VEE/CHIKV induced a wide range of IFN-dependent genes (more than 100 genes encoding a variety of transcription factors, antigen presentation genes, etc). Interestingly, the most inefficiently replicating VEE/IRES/CHIKV1 variant (Fig. 8C) induced the highest number of cellular genes and was also the most efficient in IFN-␤ induction (Fig. 8B) . The designed chimeras were tested for their rates of replication in Vero cells, which are widely used for vaccine production (Fig. 8D) . These viruses demonstrated significant differences in replication efficiencies, which appeared to be strongly determined by the levels of capsid protein expression. In Vero cells, VEE/IRES-C/CHIKV2 produced higher levels of glycoproteins than did VEE/IRES/CHIKV1 (Fig. 7B and C) , but both viruses replicated at similar reduced rates, which correlated with their low levels of capsid protein synthesis ( Fig. 7B  and C) .
The chimeric viruses were also tested in mosquito cells for their ability to develop productive infection. In C7/10 cells, the IRES-independent VEE/CHIKV replicated to titers above 10 9 IFU/ml; however, titers of the IRES-dependent variants were below the limits of detection (Fig. 8E) .
Chimeric, IRES-containing viruses induce neutralizing Abs. The chimeric, IRES-containing viruses differ strongly from their counterparts in terms of the coding strategies of their genomes. Additionally, they lack the genes whose products interfere with cellular transcription. Thus, the ability of these viruses to replicate in cells having intact type I IFN signaling is strongly hindered. This, in turn, might have a strong negative impact on their ability to induce a protective immune response, affecting primarily the production of CHIKV-specific neutralizing Abs. To demonstrate that the designed IRES-containing chimeras remain immunogenic, we infected 6-week-old female CD1 mice with 10 5 PFU of the following: (i) VEE/CHIKV/ IRESe/C1, which is the most efficient in replication in vitro, (ii) EEE/CHIKV/IRESe/C, which had the same genome strategy as VEE/CHIKV/IRESe/C1 but was designed on the basis of the EEEV South American strain BeAr436087 genome, and (iii) CHIKV 181-25, which is a U.S. military investigational vaccine, produced by serial passages of a Thai CHIKV strain in MRC-5 cells (36) . Neutralizing Abs were evaluated using the PRNT 80 at days 28 and 120 postinfection. Chimeras did not induce any detectable disease, and all the mice seroconverted. Titers of the induced neutralizing antibodies were comparable to those induced by CHIKV 181-25. EEE/CHIKV/IRESe/C induced detectably lower Ab titers, but this could be the result of using a limited number of mice. Compared to VEE/CHIKV and CHIKV 181-25, this chimeric virus was also less efficient in the induction of CHIKV-specific IgM (data not shown).
These results demonstrated that neither the strong modifications of the viral genome nor the dependence of viruses on the EMCV IRES make alphaviruses that encode CHIKVspecific structural proteins incapable of inducing an adaptive immune response. Comparative studies using the chimeras generated in this work will be conducted in the future in order to determine the safety (in immunocompromized mice), effi- cacy, replication in different tissues, and induction of cytokines and both humoral and cellular components of the adaptive immune response.
DISCUSSION
Within the last decades, the virology field has experienced great progress in terms of understanding the mechanisms of replication of different viruses, uncovering functions of virusspecific proteins, and understanding virus-host cell interactions. Some of the viral proteins bearing functions in downregulation of the host innate immune response became of particular interest (9-12, 29, 38, 39, 46, 58) . Identification of such proteins and inhibition of this activity have become an important direction of the research into development of attenuated viruses that can efficiently replicate in tissue culture but are incapable of inducing high-titer viremia and disease development in vivo.
Alphaviruses are not an exception. A great deal of progress has been made in the studies of the structure of viral particles, virus-specific protein complexes, and the function of viral proteins in RNA replication and modification of the intracellular environment (23, 25, 26, 30) . All of the alphaviruses exhibit the same genome strategy and demonstrate a high level of identity in both structural and nonstructural proteins; however, they strongly differ in the means that they utilize for interference with the innate immune response (25, 26) . The virus-specific modes of regulation of the antiviral response provide an interesting opportunity for the rational design of new alphavirus variants demonstrating a programmed, attenuated phenotype and expressing a high level of structural proteins, which can serve as efficient immunogens. It would be also very beneficial for such viruses to encode additional safety features, such as an inability to replicate in mosquito vectors, which prevents them from entering the natural transmission cycle.
In this study, the strategy for designing such attenuated alphaviruses was based on the following data. (i) The nsP2 protein of the New World alphaviruses (EEEV and VEEV) does not interfere with cellular nuclear functions to the same extent as the corresponding protein in the Old World alphaviruses (SINV, SFV, and most likely CHIKV) (3, 4, 6, 26) . (ii) Capsid proteins of the Old World alphaviruses, in contrast to the New World alphavirus-specific capsids, do not block nuclear cytoplasmic trafficking and cause no inhibition of cellular transcription (24, 26) . (iii) VEEV replicons and VEEV variants with certain mutations in capsid protein induce high levels of cytokines and have been proposed as efficient biological adjuvants (15, (51) (52) (53) (54) . (iv) Alphavirus structural proteins (capsid, E2, and E1) efficiently package RNA genomes, in which all of the nonstructural genes and cis-acting promoter elements are derived from heterologous alphaviruses (7, 18, 31, 40, 56, 57) . (v) The EMCV IRES and in all likelihood those derived from other viruses having no arthropod-specific stage in their life cycle do not function in mosquito cells (55) . Taken together, these data provided an opportunity for a wide range of genetic manipulations aimed at designing IRES-dependent recombinant alphaviruses incapable of interfering with the antiviral response and potentially applicable as live attenuated vaccines.
In this study, we used CHIKV-specific structural polyprotein-coding genes to optimize the strategy of designing attenuated alphaviruses that could be potentially used as live vaccine candidates. The first step was to define an optimal backbone for the recombinant genome. Thus, we initially designed chimeras encoding replicative machineries derived from three different alphaviruses and structural proteins of CHIKV. The microarray analysis of the cellular response to replication of these viruses demonstrated that the VEEV TC-83-based chimera backbone leads to activation of a wider range of cellular genes, many of which represent IFN-stimulated genes (ISGs). Another important finding was that an increase in titers of the chimeric viruses harvested from Vero cells required mutations in the CHIKV E2 glycoprotein gene, which was originally derived from the natural CHIKV isolate. It is highly unlikely that this adaptive mutation had an effect on the rates of virus release or their physical titers. Most likely it resulted in increased infectivity of the released virions to Vero cells and thus a changed particle/PFU ratio.
In the next experiments, we investigated three different strategies for producing chimeric viruses whose replication was dependent on the function of the EMCV IRES. Application of this IRES in addition to natural alphavirus cis-acting RNA elements makes the recombinant viruses not only incapable of replication in mosquito cells but also allows for differential regulation of expression of the structural genes. This IRES appears to be very efficient in translation of viral proteins, but it might serve as nonessential heterologous genetic material. It has been shown that insertion of the IRES in place of the 5ЈUTR of the subgenomic RNA transcribed from the subgenomic promoter leads to its almost complete deletion and reversion of the translation of structural genes to a cap-dependent mechanism (55) . With this in mind, the IRES-containing chimeras were designed in such a way as to make IRES deletion an event that makes the virus no longer viable. Thus, the EMCV IRES was initially cloned between the nonstructural and structural genes, which were no longer under the control of the subgenomic promoter due to inactivation by numerous synonymous mutations. Analysis of this construct's replication revealed a disadvantageous feature: a low level of structural protein expression, for which there are two possible explanations. First, the lack of SG RNA synthesis results in a significant decrease in production of structural polyprotein-coding mRNA templates. Second, at the late stages of infection, in contrast to subgenomic RNA, most of the IRES-containing genomic RNAs are likely to be packaged into nucleocapsids and thus excluded from translation. While a low level of structural protein expression adds another safety feature to the chimeras, it may make this type of virus poorly immunogenic, as we have previously detected for the VEEV/IRES construct (55) .
In another approach aimed at increasing the expression of all the viral structural genes but leaving capsid translation dependent on the IRES, we placed the IRES/capsid cassette downstream of the E3-E2-6K-E1-coding sequence in the subgenomic RNA. Deletion of the IRES would make the virus incapable of capsid expression and thus nonviable. Formation of an IRES-independent, viable variant would require multiple rounds of RNA recombination and thus appears to be a very rare event. Indeed, to this point, such an event has not been detected in our experiments. One of the interesting features of VOL. 85, 2011 DESIGN OF ATTENUATED CHIMERIC ALPHAVIRUSES 4373 this IRES-dependent chimeric virus was its detectable evolution to a more efficiently replicating phenotype. This resulted from the appearance of adaptive mutation in VEEV nsP2, causing an increase in transcription of the subgenomic RNA, which promoted virus replication (Fig. 5) . However, this adaptation did not change the important characteristics of the virus, namely, induction of the antiviral response and type I IFN release (Fig. 8) , but rather improved expression of structural proteins and virus production in tissue culture. This variant remained nonpathogenic for CD1 mice but induced CHIKV-specific neutralizing Abs, having a mean PRNT 80 titer of 544 (Fig. 9) , which was comparable to that induced by CHIKV 181-25. The latter investigational vaccine is immunogenic not only in mice but also in humans. However, it demonstrated some adverse reactions in human trials (16) , its attenuated phenotype relies on a very limited number of mutations, and its ability to replicate in mosquitoes leaves a possibility for virus involvement in the natural transmission cycle and further evolution to a more pathogenic phenotype. The next generation of constructs combined the best characteristics of VEE/IRES/CHIKV and VEE/CHIKV/IRESe/C in the same recombinant variant, VEE/IRES-C/CHIKV2. We intended to develop an alphavirus that demonstrated inefficient replication in terms of production of infectious virions but expressed a high level of the immunogenic CHIKV glycoproteins E2 and E1. To achieve this, the CHIKV capsid protein was expressed directly from the viral genomic RNA via IRES-dependent translation, and glycoproteins were expressed from the subgenomic RNA via the cap-dependent mechanism. This variant demonstrated lower growth rates and replicated to titers lower than those of VEE/CHIKV but expressed E2 and E1 glycoproteins with similar and even higher efficiency (see Fig. 7 and 8) . Interestingly, this new genomic arrangement also caused adaptation of nonstructural protein nsP2, which made the virus capable of replication in Vero cells to titers that we consider reasonable for large-scale production (above 10 8 IFU/ml). Accumulation of the majority of mutations in nsP2 suggests that they might be essential for RNA synthesis of the highly folded IRES sequence and/or other modifications of RNA synthesis (though other explanations are also possible). In any case, combining the identified adaptive mutations in cDNA clones of the recombinant genomes appears to prevent further evolution, and no further increase in replication was detected in the following experiments (data not shown). As observed in the experiments with other chimeric viruses (Fig. 3) , the adapted VEE/IRES-C/CHIKV2 retained an ability to activate the antiviral response. It also expressed a higher level of glycoproteins than did VEE/IRES/CHIKV, significant since it has been previously demonstrated that the plasma membrane-associated glycoproteins induce a high level of protective immune response even in the absence of viral particle release (49) .
Taken together, the results of this study demonstrate that our current knowledge of the mechanism of alphavirus replication, which certainly remains far from complete, provides a unique opportunity for the rational design of variants with an irreversibly attenuated phenotype. Our data suggest that combining of structural and nonstructural genes encoding no proteins with nuclear functions makes such viruses efficiently replicating in the cells competent in type I production and signaling but incapable of interfering with the development of the antiviral response in IFN-competent cells. Their replication leads to efficient type I IFN induction and does not inhibit activation of the virus-induced cell response and IFN-inducible genes. Construction of these variants in such a way as to make their replication IRES dependent adds the additional safety feature of an inability to replicate in mosquito cells, thus excluding these viruses from the natural transmission cycle. These recombinant viruses are expected to replicate inefficiently in immunocompetent hosts and will most likely be able to induce just a single round of self-limiting infection, sufficient, however, for induction of the adaptive immune response. Comparative in vivo experiments are currently being performed.
It should be noted that in the case of alphaviruses, a combination of structural and nonstructural proteins having no nuclear functions and use of IRESes for differential regulation of the structural genes are not the only means of viral attenuation. Their rates of replication can also be strongly modified by mutating the packaging signals and/or introducing mutations into the RNA-binding domains of capsid protein. However, alphaviruses demonstrate an outstanding plasticity, and their ability to accumulate adaptive mutations in response to deliberate modification of their genomes is always a possibility that should be investigated.
